Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
Identifieur interne : 006142 ( Main/Exploration ); précédent : 006141; suivant : 006143Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
Auteurs : Devan Krishnamurthy [États-Unis] ; Vivian Weinberg ; J Adam M. Cunha ; I-Chow Hsu ; Jean PouliotSource :
- Brachytherapy [ 1873-1449 ]
Descripteurs français
- KwdFr :
- Adénocarcinome (radiothérapie), Curiethérapie (), Dosimétrie en radiothérapie, Humains, Mâle, Planification de radiothérapie assistée par ordinateur (), Radio-isotopes, Radio-isotopes de l'iridium (usage thérapeutique), Radiométrie, Thulium (usage thérapeutique), Tumeurs de la prostate (radiothérapie), Ytterbium (usage thérapeutique).
- MESH :
- radiothérapie : Adénocarcinome, Tumeurs de la prostate.
- usage thérapeutique : Radio-isotopes de l'iridium, Thulium, Ytterbium.
- Curiethérapie, Dosimétrie en radiothérapie, Humains, Mâle, Planification de radiothérapie assistée par ordinateur, Radio-isotopes, Radiométrie.
English descriptors
- KwdEn :
- Adenocarcinoma (radiotherapy), Brachytherapy (methods), Humans, Iridium Radioisotopes (therapeutic use), Male, Prostatic Neoplasms (radiotherapy), Radioisotopes, Radiometry, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted (methods), Thulium (therapeutic use), Ytterbium (therapeutic use).
- MESH :
- chemical , therapeutic use : Iridium Radioisotopes, Thulium, Ytterbium.
- methods : Brachytherapy, Radiotherapy Planning, Computer-Assisted.
- radiotherapy : Adenocarcinoma, Prostatic Neoplasms.
- Humans, Male, Radioisotopes, Radiometry, Radiotherapy Dosage.
Abstract
Recent studies have identified that among different available radionuclides, the dose characteristics and shielding properties of ytterbium-169 ((169)Yb) and thulium-170 ((170)Tm) may suit high-dose rate (HDR) brachytherapy needs. The purpose of this work was to compare clinically optimized dose distributions using proposed (169)Yb and (170)Tm HDR sources with the clinical dose distribution from a standard microSelectron V2 HDR iridium-192 ((192)Ir) brachytherapy source (Nucletron B.V., Veenendaal, The Netherlands).
DOI: 10.1016/j.brachy.2011.01.012
PubMed: 21397569
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000447
- to stream PubMed, to step Curation: 000447
- to stream PubMed, to step Checkpoint: 000447
- to stream Ncbi, to step Merge: 000451
- to stream Ncbi, to step Curation: 000451
- to stream Ncbi, to step Checkpoint: 000451
- to stream Main, to step Merge: 006596
- to stream Main, to step Curation: 006142
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.</title><author><name sortKey="Krishnamurthy, Devan" sort="Krishnamurthy, Devan" uniqKey="Krishnamurthy D" first="Devan" last="Krishnamurthy">Devan Krishnamurthy</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143-1708, USA. KrishnamurthyD@radonc.ucsf.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143-1708</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Weinberg, Vivian" sort="Weinberg, Vivian" uniqKey="Weinberg V" first="Vivian" last="Weinberg">Vivian Weinberg</name></author><author><name sortKey="Cunha, J Adam M" sort="Cunha, J Adam M" uniqKey="Cunha J" first="J Adam M" last="Cunha">J Adam M. Cunha</name></author><author><name sortKey="Hsu, I Chow" sort="Hsu, I Chow" uniqKey="Hsu I" first="I-Chow" last="Hsu">I-Chow Hsu</name></author><author><name sortKey="Pouliot, Jean" sort="Pouliot, Jean" uniqKey="Pouliot J" first="Jean" last="Pouliot">Jean Pouliot</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2011 Nov-Dec</MedlineDate></PubDate></date><idno type="doi">10.1016/j.brachy.2011.01.012</idno><idno type="RBID">pubmed:21397569</idno><idno type="pmid">21397569</idno><idno type="wicri:Area/PubMed/Corpus">000447</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000447</idno><idno type="wicri:Area/PubMed/Curation">000447</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000447</idno><idno type="wicri:Area/PubMed/Checkpoint">000447</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000447</idno><idno type="wicri:Area/Ncbi/Merge">000451</idno><idno type="wicri:Area/Ncbi/Curation">000451</idno><idno type="wicri:Area/Ncbi/Checkpoint">000451</idno><idno type="wicri:Area/Main/Merge">006596</idno><idno type="wicri:Area/Main/Curation">006142</idno><idno type="wicri:Area/Main/Exploration">006142</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.</title><author><name sortKey="Krishnamurthy, Devan" sort="Krishnamurthy, Devan" uniqKey="Krishnamurthy D" first="Devan" last="Krishnamurthy">Devan Krishnamurthy</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143-1708, USA. KrishnamurthyD@radonc.ucsf.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143-1708</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Weinberg, Vivian" sort="Weinberg, Vivian" uniqKey="Weinberg V" first="Vivian" last="Weinberg">Vivian Weinberg</name></author><author><name sortKey="Cunha, J Adam M" sort="Cunha, J Adam M" uniqKey="Cunha J" first="J Adam M" last="Cunha">J Adam M. Cunha</name></author><author><name sortKey="Hsu, I Chow" sort="Hsu, I Chow" uniqKey="Hsu I" first="I-Chow" last="Hsu">I-Chow Hsu</name></author><author><name sortKey="Pouliot, Jean" sort="Pouliot, Jean" uniqKey="Pouliot J" first="Jean" last="Pouliot">Jean Pouliot</name></author></analytic><series><title level="j">Brachytherapy</title><idno type="eISSN">1873-1449</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (radiotherapy)</term><term>Brachytherapy (methods)</term><term>Humans</term><term>Iridium Radioisotopes (therapeutic use)</term><term>Male</term><term>Prostatic Neoplasms (radiotherapy)</term><term>Radioisotopes</term><term>Radiometry</term><term>Radiotherapy Dosage</term><term>Radiotherapy Planning, Computer-Assisted (methods)</term><term>Thulium (therapeutic use)</term><term>Ytterbium (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adénocarcinome (radiothérapie)</term><term>Curiethérapie ()</term><term>Dosimétrie en radiothérapie</term><term>Humains</term><term>Mâle</term><term>Planification de radiothérapie assistée par ordinateur ()</term><term>Radio-isotopes</term><term>Radio-isotopes de l'iridium (usage thérapeutique)</term><term>Radiométrie</term><term>Thulium (usage thérapeutique)</term><term>Tumeurs de la prostate (radiothérapie)</term><term>Ytterbium (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Iridium Radioisotopes</term><term>Thulium</term><term>Ytterbium</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Brachytherapy</term><term>Radiotherapy Planning, Computer-Assisted</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Adenocarcinoma</term><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Adénocarcinome</term><term>Tumeurs de la prostate</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Radio-isotopes de l'iridium</term><term>Thulium</term><term>Ytterbium</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Male</term><term>Radioisotopes</term><term>Radiometry</term><term>Radiotherapy Dosage</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Curiethérapie</term><term>Dosimétrie en radiothérapie</term><term>Humains</term><term>Mâle</term><term>Planification de radiothérapie assistée par ordinateur</term><term>Radio-isotopes</term><term>Radiométrie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Recent studies have identified that among different available radionuclides, the dose characteristics and shielding properties of ytterbium-169 ((169)Yb) and thulium-170 ((170)Tm) may suit high-dose rate (HDR) brachytherapy needs. The purpose of this work was to compare clinically optimized dose distributions using proposed (169)Yb and (170)Tm HDR sources with the clinical dose distribution from a standard microSelectron V2 HDR iridium-192 ((192)Ir) brachytherapy source (Nucletron B.V., Veenendaal, The Netherlands).</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><noCountry><name sortKey="Cunha, J Adam M" sort="Cunha, J Adam M" uniqKey="Cunha J" first="J Adam M" last="Cunha">J Adam M. Cunha</name><name sortKey="Hsu, I Chow" sort="Hsu, I Chow" uniqKey="Hsu I" first="I-Chow" last="Hsu">I-Chow Hsu</name><name sortKey="Pouliot, Jean" sort="Pouliot, Jean" uniqKey="Pouliot J" first="Jean" last="Pouliot">Jean Pouliot</name><name sortKey="Weinberg, Vivian" sort="Weinberg, Vivian" uniqKey="Weinberg V" first="Vivian" last="Weinberg">Vivian Weinberg</name></noCountry><country name="États-Unis"><region name="Californie"><name sortKey="Krishnamurthy, Devan" sort="Krishnamurthy, Devan" uniqKey="Krishnamurthy D" first="Devan" last="Krishnamurthy">Devan Krishnamurthy</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006142 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006142 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21397569
|texte= Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21397569" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |